MA07.02 Updated Efficacy and Safety Data from the Phase 2 NP28761 Study of Alectinib in ALK-Positive Non-Small-Cell Lung Cancer

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共1页
• 作者

  D. Ross Camidge; Shirish Gadgeel; Sai-Hong Ou; Leena Gandhi; Gregory Riely; Jeremy Cetnar; Howard West; Mark Socinski; Alberto Chiappori; Tarek Mekhail; Bo Chao; Hossein Borghaei; Kathryn Gold; Walter Bordogna; Bogdana Balas; Johannes Noe; Sophie Golding; Ali Zeaiter; Alice Shaw;

  展开▼
• 作者单位

  University of Colorado;

  Karmanos Cancer Institute/wayne State University;

  University of California Irvine School of Medicine;

  Dana-Farber Cancer Institute;

  Memorial Sloan Kettering Cancer Center;

  Oregon Health and Sciences University;

  Swedish Cancer Institute;

  University of Pittsburgh Medical Center;

  Moffitt Cancer Center;

  Florida Hospital Cancer Institute;

  Ohio State University;

  Fox Chase Cancer Center;

  Thoracic Medical Oncology MD Anderson Cancer Center;

  F. Hoffmann-La Roche;

  F. Hoffmann-La Roche;

  F. Hoffmann-La Roche;

  F. Hoffmann-La Roche;

  F. Hoffmann-La Roche;

  Massachusetts General Hospital;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词